Louisville Medicine Volume 64 Issue 1, | Page 34

GLMS INSURANCE UPDATES HUMANA Vasu Kakarlapudi, MD D id you know that GLMS meets with five insurance payers quarterly to discuss updates from the payers and hassles that have been reported by GLMS members? Below are the main points from our Quarter Two Humana meeting. • Senate Bill 18 - Senate Bill 18 requires insurers to follow a new and fairer set of procedures before changing an existing agreement with a provider. This law goes into effect January 1, 2017, and contracts written after July 1, 2016, must adhere to these changes. The role of GLMS will be to communicate and provide education to members on the provisions of Senate Bill 18. Specifically, SB 18 requires: - ninety (90) days’ notice for a material change; - notices for material changes dealing with membership networks or new/modified insurance products to be sent by certified mail - notices for all other material changes to be sent in an orange-colored envelope; - notices that describe the material changes; - an opportunity for providers to use “real-time communication” to discuss the proposed changes with the insurer; - a clean, consolidated informational copy of the agreement after three (3) material changes in a twelve (12) month period; and - an opportunity for providers to object to proposed material 32 LOUISVILLE MEDICINE changes by utilizing specifically defined procedures. • Humana Provider Simplification Process - Humana is rolling out a process to keep practices from having to contact multiple representatives based on the reason for their call. Noting that having various people assigned to different roles can be counterproductive, Humana created the Provider Simplification Process. Providers will be assigned one “go-to” provider representative within Humana to help them resolve issues, answer questions, or assist them in whichever way they need. The assigned person will be empowered to make decisions affecting the provider and resolve their concerns. This process is slated to begin in the Kentucky market in September. • Use of Out-of-Network Labs – Humana has identified an increase in utilization of out-of-network labs, specifically for broad panel drug testing. Use of out-of-network labs may result in higher costs to the patient. • Value Based Contracting – Continued discussion on value based contracting and pay for performance. Humana has expressed interest in learning new ways to incentivize physicians for improving patient care, patient experience and cost of care. Look for more information in the coming months as the GLMS Insurance Issues Resolution Committee continues to work to resolve the most pressing issues you face each day. Vasu Kakarlapudi, MD, is an otolaryngologist with Advanced ENT & Allergy and Chair of the IIRC Humana Committee.